XML 69 R46.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SHARE-BASED PAYMENTS (Tables)
12 Months Ended
Dec. 31, 2023
SHARE-BASED PAYMENTS  
Summary of the activity under the share option scheme

A summary of the activity for the options granted under the 2013 Share Option Scheme is stated below:

Weighted-

Weighted-

Weighted-

average

average

Aggregate

Number of

average exercise

grant-date

remaining

intrinsic

    

options

    

price

    

fair value

    

contractual term

    

value

US$

US$

Years

US$

Outstanding, December 31, 2022

 

38,366,108

 

0.07

 

0.86

 

6.01

 

6,972

Forfeited

 

(1,147,119)

 

0.07

 

1.84

 

 

Exercised

 

(4,363,286)

 

0.07

 

0.63

 

 

Outstanding, December 31, 2023

 

32,855,703

 

0.07

 

0.85

 

5.01

 

5,864

Vested and expected to vest at December 31, 2023

 

32,855,703

 

0.07

 

0.85

 

5.01

 

5,864

Exercisable at December 31, 2023

 

27,962,196

 

0.07

 

0.68

 

4.68

 

4,994

Summary of the activity for the options issued under the share award scheme

A summary of the activity for the options granted under the 2013 Share Award Scheme is stated below:

Weighted-

Weighted-

Weighted-

average

average

Aggregate

Number of

average exercise

grant-date

remaining

intrinsic

    

options

    

price

    

fair value

    

contractual term

    

value

US$

US$

Years

US$

Outstanding, December 31, 2022

 

17,068,100

 

0.87

 

0.31

 

6.97

 

Forfeited

 

(2,611,210)

 

0.87

 

0.29

 

 

Outstanding, December 31, 2023

 

14,456,890

 

0.87

 

0.32

 

5.97

 

Vested and expected to vest at December 31, 2023

 

14,456,890

 

0.87

 

0.32

 

5.97

 

Exercisable at December 31, 2023

 

12,391,620

 

0.87

 

0.31

 

5.96

 

Schedule of assumptions used to estimate the fair value of the share options

The assumptions used to estimate the fair value of the share options granted for the years ended December 31, 2021 and 2022 are as follows:

For the year ended December 31

    

2021

    

2022

Risk-free rate

 

1.13%-1.62%

1.75%-2.93%

Expected volatility range

 

36.28%-38.03%

35.62%-46.22%

Exercise multiple

 

2.20-2.80

 

2.20-2.80

Fair market value per ordinary share as at valuation dates

 

US$1.97-US$3.49

 

US$0.24-US$0.73

Summary of acquisition date fair value of each share-based award is estimated

The acquisition date fair value of each Camelot Award is estimated using the binomial tree option pricing model with the following assumptions:

    

2021

 

Risk-free rate

 

0.21

%

Expected volatility

 

50.56

%

Exercise multiple

 

2.20

Fair market value per ordinary share as at valuation dates

 

RMB23.00

Summary of the amount of share-based compensation expense included in each of the relevant financial statement line items

The following table sets forth the amount of share-based compensation expense included in each of the relevant financial statement line items:

For the year ended December 31

    

2021

    

2022

    

2023

    

2023

RMB

RMB

RMB

US$

Cost of revenues

 

17,481

 

15,618

 

9,757

 

1,374

Selling and marketing expenses

 

72,594

 

68,562

 

6,977

 

983

General and administrative expenses

 

193,886

 

187,843

 

114,766

 

16,164

Research and development expenses

 

150,389

 

87,812

 

50,145

 

7,063

 

434,350

 

359,835

 

181,645

 

25,584

2013 Share Award Scheme  
SHARE-BASED PAYMENTS  
Summary of the activity for the restricted shares issued under the share award scheme

A summary of the activity for the restricted shares issued under the 2013 Share Award Scheme is stated below:

Number of

Weighted-average

    

shares

    

grant-date fair value

US$

Outstanding, December 31, 2022

 

30,148,902

 

1.33

Vested

 

(9,271,339)

 

1.08

Forfeited

 

(7,740,183)

 

1.45

Outstanding, December 31, 2023

 

13,137,380

 

1.22

Expected to vest at December 31, 2023

 

13,137,380

 

1.22

2021 Share Award Scheme  
SHARE-BASED PAYMENTS  
Summary of the activity for the options issued under the share award scheme

In November 2021, the Company adopted the 2021 Share Award Scheme. A summary of the activity for the restricted shares with option features (the “RSUs”) issued under the 2021 Share Award Scheme is stated below:

    

    

Weighted- 

    

    

average 

Weighted- 

Weighted- 

grant- 

average 

Aggregate 

Number of 

average exercise 

date 

remaining 

intrinsic 

    

the RSUs

    

price

    

fair value

    

contractual term

    

value

US$

US$

Years

US$

Outstanding, December 31, 2022

 

104,003,481

 

0.01

 

0.32

 

9.44

 

25,786

Granted

 

154,646,877

 

0.01

 

0.27

 

 

Exercised

 

(40,048,900)

 

0.01

 

0.28

 

 

Forfeited

 

(12,449,108)

 

0.01

 

0.37

 

 

Outstanding, December 31, 2023

 

206,152,350

 

0.01

 

0.29

 

9.38

 

54,682

Vested and expected to vest at December 31, 2023

 

206,152,350

 

0.01

 

0.29

 

9.38

 

54,682

Exercisable at December 31, 2023

 

63,021,373

 

0.01

 

0.26

 

9.23

 

15,251